Survivin inhibitors target a protein called survivin, which is a fascinating player in the realm of cell survival. Survivin is often overexpressed in cancer cells and contributes to their uncontrolled growth. Inhibitors of survivin can thwart this process, making them promising candidates in cancer therapy. By blocking survivin's action, these inhibitors promote programmed cell death (apoptosis) and can help curb the growth of cancerous tissues. They hold potential in the fight against various cancers.
